Brugada syndrome with marked conduction disease: dual implications of a SCN5A mutation.
A 51-year-old woman presented with an episode of syncope. Upon further review she was found to have a typical Brugada type pattern on her electrocardiogram. She did not have evidence for structural heart disease. At electrophysiological testing she was found to have marked infrahisian conduction disease and had easily inducible polymorphic ventricular tachycardia. She underwent implantation of a dual-chamber implantable cardioverter defibrillator (ICD) and family screening was recommended. Genetic analysis revealed a novel nonsense mutation in the gene encoding for the sodium channel (SCN5A). Five months after ICD implantation the patient had an episode of ventricular fibrillation documented on ICD interrogation. This case is unique as it is consistent with an overlap syndrome, namely both Brugada Syndrome and distal atrioventricular (AV) conduction disease secondary to a novel SCN5A mutation in a young female. This finding highlights the phenotypic heterogeneity of novel SCN5A mutations.
Vorobiof
Gabriel
G
Electrophysiology Service & Cardiology Unit, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA. g_voro@yahoo.com
Kroening
Daniel
D
Hall
Burr
B
Brugada
Ramon
R
Huang
David
D
D054537:Atrioventricular Block / Q000175:diagnosis* / Q000235:genetics* / Q000517:prevention & control; D053840:Brugada Syndrome / Q000175:diagnosis* / Q000235:genetics* / Q000517:prevention & control; D017147:Defibrillators, Implantable; D003937:Diagnosis, Differential; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D008875:Middle Aged